Imaging biomarkers to monitor response to the hypoxia-activated prodrug TH-302 in the MiaPaCa2 flank xenograft model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Imaging biomarkers to monitor response to the hypoxia-activated prodrug TH-302 in the MiaPaCa2 flank xenograft model

Published:2012-09 Issue:7 Volume:30 Page:1002-1009
ISSN:0730-725X
Container-title:Magnetic Resonance Imaging
language:en
Short-container-title:Magnetic Resonance Imaging

Author:

Cárdenas-Rodríguez Julio,Li Yuguo,Galons Jean-Philippe,Cornnell Heather,Gillies Robert J.,Pagel Mark D.,Baker Amanda F.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Biomedical Engineering,Biophysics

Reference24 articles.

1. Hypoxia-mediated biological control;Cassavaugh;J Cell Biochem,2011

2. Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer;Duffy;Mol Cancer,2003

3. Hypoxia-activated prodrugs in cancer therapy: progress to the clinic;Denny;Future Oncol,2010

4. Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs;Duan;J Med Chem,2008

5. Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug;Hu;Blood,2010

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluations of radiotherapy in small animal models of pancreatic cancer with oxygen enhanced–dynamic contrast enhanced multispectral optoacoustic tomography (OE-DCE MSOT);Photons Plus Ultrasound: Imaging and Sensing 2023;2023-03-09

2. Assessing the therapeutic response of tumors to hypoxia-targeted prodrugs with an <i>in silico</i> approach;Mathematical Biosciences and Engineering;2022

3. Hypoxia-Activated Prodrug Evofosfamide Treatment in Pancreatic Ductal Adenocarcinoma Xenografts Alters the Tumor Redox Status to Potentiate Radiotherapy;Antioxidants & Redox Signaling;2021-10-10

4. Deep-learning and MR images to target hypoxic habitats with evofosfamide in preclinical models of sarcoma;Theranostics;2021

5. Targeting hypoxic habitats with hypoxia pro-drug evofosfamide in preclinical models of sarcoma;2020-10-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3